LYMPHOMA, B-CELL
Clinical trials for LYMPHOMA, B-CELL explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, B-CELL trials appear
Sign up with your email to follow new studies for LYMPHOMA, B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
PET-Guided strategy may improve outcomes in aggressive lymphoma
Disease control CompletedThis study tested two different chemotherapy combinations (R-ACVBP and R-CHOP) along with the targeted drug rituximab in 222 adults aged 18-59 with an aggressive type of B-cell lymphoma. Participants had 2 or 3 risk factors that make the disease harder to treat. The researchers u…
Matched conditions: LYMPHOMA, B-CELL
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated May 17, 2026 04:30 UTC
-
New pill shows promise for hard-to-treat blood cancers
Disease control CompletedThis study tested an oral drug called LOXO-305 in 87 Chinese adults with lymphoma or chronic lymphocytic leukemia who had already received standard treatments. The goal was to see how safe and effective the drug is. Participation could last up to four years. The study is now comp…
Matched conditions: LYMPHOMA, B-CELL
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 17, 2026 04:16 UTC
-
New drug combo shows promise against Hard-to-Treat lymphomas
Disease control CompletedThis study tested a combination of two drugs, favezelimab and pembrolizumab, in 137 people with Hodgkin lymphoma and other B-cell blood cancers. The goal was to see if the combo is safe and can shrink tumors. Participants received the drugs alone or together, and researchers moni…
Matched conditions: LYMPHOMA, B-CELL
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New radiation schedule aims to ease path to CAR t for lymphoma patients
Disease control CompletedThis study tested a new radiation therapy schedule for people with B-cell lymphoma that has come back or not responded to treatment. Participants received radiation once a week for five weeks before their CAR T-cell therapy. The goal was to see if this schedule makes radiation ea…
Matched conditions: LYMPHOMA, B-CELL
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Engineered donor cells take aim at returning blood cancers
Disease control CompletedThis study tested a new treatment for people whose B-cell cancers (like lymphoma or leukemia) came back after a donor stem cell transplant. Researchers took immune cells from the original donor, modified them to better recognize and attack cancer cells, and gave them to 85 patien…
Matched conditions: LYMPHOMA, B-CELL
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
Lifting weights during chemo: a new way to fight muscle loss?
Symptom relief CompletedThis study looked at whether a 4-month supervised strength training program could help people with lymphoma keep their muscle mass while undergoing chemotherapy. 42 patients were split into two groups: one did resistance training, the other received usual care. The main goal was …
Matched conditions: LYMPHOMA, B-CELL
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated May 17, 2026 04:29 UTC
-
HIV Patients' CAR T-Cell outcomes under the microscope
Knowledge-focused CompletedThis study looked back at 30 people with HIV who had already received CAR T-cell therapy for certain blood cancers. Researchers collected standard medical data to see what side effects occurred and how the immune system changed over time. The goal was to learn more about safety a…
Matched conditions: LYMPHOMA, B-CELL
Sponsor: AIDS Malignancy Consortium • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC